Skip to Content
Get key facts and figures about chronic dry eye

Levobetaxolol ophthalmic Pregnancy and Breastfeeding Warnings

Levobetaxolol ophthalmic is also known as: Betaxon

Levobetaxolol ophthalmic Pregnancy Warnings

Levobetaxolol ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity, but increased post-implantation loss occurred at 12 mg/kg/day and an increased incidence of sternebrae malformations occurred at 4 mg/kg/day in rats and rabbits. There are no controlled data during human pregnancy. Levobetaxolol is only recommended for use during pregnancy when benefit outweighs risk.

See references

Levobetaxolol ophthalmic Breastfeeding Warnings

There are no data on the excretion of levobetaxolol into human milk. Racemic betaxolol has been reported to be excreted into human milk after oral administration. Other beta-blockers and topical timolol maleate are excreted in milk. In general, most experts recommend monitoring of nursing infants for signs and symptoms of beta-blockade, such as bradycardia and hypoglycemia. The manufacturer recommends caution when administering levobetaxolol ophthalmic to nursing women.

See references

References for pregnancy information

  1. "Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.

References for breastfeeding information

  1. "Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.